H.C. Wainwright Starts Heat Biologics (HTBX) at Buy June 26, 2018 7:03 AM EDT H.C. Wainwright initiates coverage on Heat Biologics (NASDAQ: HTBX) with a Buy rating and a price target of $6.00.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.